Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.59 |
| ▸ | MAOB | P27338 | 2/20 | 0.59 |
| ▸ | DRD2 | P14416 | 2/20 | 0.45 |
| ▸ | DRD3 | P35462 | 2/20 | 0.45 |
| ▸ | DRD1 | P21728 | 1/20 | 0.45 |
| ▸ | DRD5 | P21918 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA4 | P22748 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA6 | P23280 | 2/20 | 0.42 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.42 |
| ▸ | BAD | Q92934 | 1/20 | 0.42 |
| ▸ | MAPKAPK2 | P49137 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL6129306 | 0.98 | MAOA (0.57) | MAOAMAOBDRD2DRD3DRD1 | |
| SCHEMBL7970202 | 0.81 | MAOA (0.55) | MAOAMAOBDRD2DRD3DRD1 | |
| SCHEMBL30346211 | 0.80 | MAOA (0.53) | MAOAMAOBCA2CA4CA1 | |
| SCHEMBL8649269 | 0.80 | MAOA (0.53) | MAOAMAOBCA2CA4CA1 | |
| SCHEMBL4809975 | 0.79 | DRD2 (0.47) | MAOAMAOBDRD2DRD3DRD1 | |
| SCHEMBL1979793 | 0.79 | MAOA (0.52) | MAOAMAOBCA2CA4CA1 | |
| Xanthene SCHEMBL2312744 | 0.79 | MAOA (0.94) | MAOAMAOBMAPKAPK2GAANPSR1 | |
| SCHEMBL5605804 | 0.78 | MAOA (0.50) | MAOAMAOBDRD2DRD3DRD1 | |
| SCHEMBL31545621 | 0.77 | MAOA (0.46) | MAOAMAOBCA2CA4CA1 | |
| SCHEMBL5094900 | 0.77 | MAOA (0.59) | MAOAMAOBDRD2DRD3DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102573469-A | Na/K-ATP enzyme ligand, ouabain G antagonist, test method and application thereof | UNIV TOLEDO | 2012-07-11 | — | — | CN | claimed |
| EP-0471794-B1 | ANTIVIRAL THERAPY USING THIAZINE AND XANTHENE DYES | OKLAHOMA MED RES FOUND (US) | 1996-10-02 | — | — | EP | claimed |
| EP-0471794-A4 | ANTIVIRAL THERAPY USING THIAZINE AND XANTHENE DYES | — | 1992-05-06 | — | — | EP | claimed |
| EP-0471794-A1 | ANTIVIRAL THERAPY USING THIAZINE AND XANTHENE DYES. | OKLAHOMA MED RES FOUND (US) | 1992-02-26 | — | — | EP | claimed |
| WO-1990013296-A1 | ANTIVIRAL THERAPY USING THIAZINE AND XANTHENE DYES | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 1990-11-15 | — | — | WO | claimed |
| JP-8151327-A | — | — | None | — | — | JP | disclosed |
| US-20240358861-A1 | COMPOSITIONS AND METHODS OF FLUORESCEIN SODIUM FOR EARLY DIAGNOSIS OF CERVICAL CANCER | THE MOEIN FAMILY TRUST (US) | 2024-10-31 | — | — | US | disclosed |
| EP-2879656-B2 | DYE COMPOSITION IN CREAM FORM COMPRISING AT LEAST ONE OIL AND LITTLE OR NO SOLID FATTY ALCOHOL, DYEING PROCESS AND SUITABLE DEVICE | OREAL (FR) | 2024-07-17 | — | — | EP | disclosed |
| US-11730682-B2 | Self-standing cosmetic sheet | L'OREAL (FR) | 2023-08-22 | — | — | US | disclosed |
| CN-110869340-B | Process for the production of 3, 7-dimethyl-9- (2, 6-trimethyl-1-cyclohexen-1-yl) -non-2E, 7E-diene-4-yne-1, 6-diol | 帝斯曼知识产权资产管理有限公司 | 2022-10-14 | — | — | CN | disclosed |
| EP-2836187-B1 | SELF-STANDING COSMETIC SHEET | OREAL (FR) | 2021-12-08 | — | — | EP | disclosed |
| EP-3395323-B1 | METHOD FOR TREATING HAIR | KAO CORP (JP) | 2021-09-29 | — | — | EP | disclosed |
| EP-0471794-A1 | ANTIVIRAL THERAPY USING THIAZINE AND XANTHENE DYES. | OKLAHOMA MED RES FOUND (US) | 1992-02-26 | — | — | EP | disclosed |
| EP-0110682-B1 | ACTIVATED ARYL CAPPED FLUORESCENT COMPOUNDS, AND ASSAY METHODS AND SYSTEMS USING THEM AS FLUOROGENIC PRECURSORS | SYVA COMPANY (US) | 1991-08-21 | — | — | EP | disclosed |
| WO-1990013296-A1 | ANTIVIRAL THERAPY USING THIAZINE AND XANTHENE DYES | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 1990-11-15 | — | — | WO | disclosed |
| US-4857455-A | WATER SOLUBLE ACTIVATED CAPPED AROMATIC FLUORESCENT COMPOUNDS | SYNTEX (U.S.A) INC. (US) | 1989-08-15 | — | — | US | disclosed |
| EP-0311010-A2 | Alpha,Alpha-disubstituted aromatics and heteroaromatics as cognition enhancers | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1989-04-12 | — | — | EP | disclosed |
| EP-0110682-A2 | Activated aryl capped fluorescent compounds, and assay methods and systems using them as fluorogenic precursors | SYVA COMPANY (US) | 1984-06-13 | — | — | EP | disclosed |
| US-4268514-A | ANALGESICS | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1981-05-19 | — | — | US | disclosed |
| US-3931298-A | FROM A HYDROXYAROMATIC AND AMMONIA, GROUP 8-CYCLOHEXANONE CATALYST | ETHYL CORPORATION (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11730682-B2 | Self-standing cosmetic sheet | CUTA, DSG1, SUCLG1 | MAOA 1465/4885MAOB 3142/4885DRD2 1619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.